Discounted Cash Flow Rating

Neutral

Return on Equity Rating

Sell

Debt to Equity Rating

Sell

Price to Earnings Rating

Buy

Analyst Rating

Sell

Simple Moving Average

Neutral

Exponential Moving Average

Neutral

Relative Strength Index

Strong Buy

Standard Deviation

Sell

Williams %R

Strong Buy

Average Directional Index

Sell

Insider Trading

Buy

Wall Street Data Solutions Rating

Neutral

B

Co-Diagnostics, Inc. Common Stock (CODX)

Surgical & Medical Instruments & Apparatus

https://www.codiagnostics.com

Co-Diagnostics Inc is a molecular diagnostics company. It develops, licenses, and commercializes molecular technologies such as lab systems (MDx device) and manufacture and sell reagents used for tests that are designed using the detection and/or analysis of nucleic acid molecules (DNA or RNA). CDI's low-cost system uses its tests to diagnose tuberculosis, Zika, hepatitis B and C, Malaria, dengue and HIV. The company's diagnostics systems enable very rapid, low-cost, sophisticated molecular testing for organisms and genetic diseases by greatly automating historically complex procedures in both the development and administration of tests.

4049 SOUTH HIGHLAND DRIVE
SALT LAKE CITY, UT

Current Price

---.--

% Change Today

0.00%

Change Amt. Today

0.00

Active Status

Active

Listing Date

07/12/2017

Market Cap

46,101,822

Shares Outstanding

30,580,000

Weighted SO

30,580,904

Total Employees

N/A

Upcoming Earnings

08/08/2024

Beta

-0.8250

Last Div

0.0000

Range

0.981-1.727

Chg

0.2047

Avg Vol

138772

Mkt Cap

46101822

Exch

NASDAQ

Country

US

Phone

801 438 1036

DCF Diff

1.4161

DCF

-0.0161

Div Yield

0.0000

P/S

7.1741

EV Multiple

-0.8557

P/FV

0.6011

Div Yield %

0.0000

P/E

-1.1584

PEG

0.0070

Payout

0.0000

Current Ratio

9.0887

Quick Ratio

8.8128

Cash Ratio

2.6122

DSO

31.3251

DIO

114.8623

Op Cycle

146.1874

DPO

146.2101

CCC

-0.0227

Gross Margin

0.2761

Op Margin

-6.4442

Pretax Margin

-5.5720

Net Margin

-5.8465

Eff Tax Rate

-0.0493

ROA

-0.4655

ROE

-0.4469

ROCE

-0.5493

NI/EBT

1.0493

EBT/EBIT

0.8646

EBIT/Rev

-6.4442

Debt Ratio

0.0320

D/E

0.0357

LT Debt/Cap

0.0230

Total Debt/Cap

0.0344

Int Coverage

-12.2114

CF/Debt

-9.7090

Equity Multi

1.1147

Rec Turnover

11.6520

Pay Turnover

2.4964

Inv Turnover

3.1777

FA Turnover

1.1471

Asset Turnover

0.0796

OCF/Share

-0.8321

FCF/Share

-0.8720

Cash/Share

1.4898

OCF/Sales

-3.9009

FCF/OCF

1.0480

CF Coverage

-9.7090

ST Coverage

-28.5451

CapEx Coverage

-20.8533

Div&CapEx Cov

-20.8533

P/BV

0.6011

P/B

0.6011

P/S

7.1741

P/E

-1.1584

P/FCF

-1.7549

P/OCF

-1.7362

P/CF

-1.7362

PEG

0.0070

P/S

7.1741

EV Multiple

-0.8557

P/FV

0.6011

DPS

0.0000

Latest Headlines (EST)

No Headlines Found

Revenue Product Segmentation